Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis

Favre, L.; Borle, F.; Velin, D.; Bachmann, D.; Bouzourene, H.; Wagnières, G.; van den Bergh, H.; Ballabeni, P.; Gabrecht, T.; Michetti, P.; Schreiber, S.; Ortner, M.-A.

doi:10.1055/s-0030-1256382

Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis

Favre, L. ; Borle, F. ; Velin, D. ; Bachmann, D.[...]

Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.

Published in:

Endoscopy, 43, 7, 604-616

Year:

2011

ISSN:

1438-8812

Keywords:

Inflammatory-Bowel-Disease ; Dependent Experimental Colitis ; Adjuvant-Enhanced Arthritis ; Delta-Aminolevulinic-Acid ; Crohns-Disease ; Barretts-Esophagus ; Light Dosimetry ; Scid Mice ; Apoptosis ; Lymphocytes

DOI:

10.1055/s-0030-1256382

Other identifiers:

View record in Web of Science